| Literature DB >> 29459676 |
Pengxia Wang1, Weixi Qin2, Pengyun Wang3, Yufeng Huang4, Ying Liu5, Rongfeng Zhang5, Sisi Li1, Qin Yang1, Xiaojing Wang1, Feifei Chen5, Jingqiu Liu5, Bo Yang6, Xiang Cheng7, Yuhua Liao7, Yanxia Wu8, Tie Ke1, Xin Tu1, Xiang Ren1, Yanzong Yang5, Yunlong Xia5, Xiaoping Luo9, Mugen Liu1, He Li9, Jingyu Liu1, Yi Xiao10, Qiuyun Chen11,12, Chengqi Xu13, Qing K Wang14,15,16.
Abstract
Atrial fibrillation (AF) is the most common arrhythmia. In 2014, two new meta-GWAS identified 5 AF loci, including the NEURL locus, GJA1 locus, CAND2 locus, and TBX5 locus in the European ancestry populations and the NEURL locus and CUX2 locus in a Japanese population. The TBX5 locus for AF was reported by us in 2013 in the Chinese population. Here we assessed the association between AF and SNPs in the NEURL, GJA1, CAND2 and CUX2 loci in the Chinese Han population. We carried out a large case-control association study with 1,164 AF patients and 1,460 controls. Significant allelic and genotypic associations were identified between NEURL variant rs6584555 and GJA1 variant rs13216675 and AF. Significant genotypic association was found between CUX2 SNP rs6490029 and AF. No association was found between CAND2 variant rs4642101 and AF, which may be due to an insufficient power of the sample size for rs4642101. Together with our previous findings, seven of fifteen AF loci (<50%) identified by GWAS in the European ancestry populations conferred susceptibility to AF in the Chinese population, and explained approximately 14.5% of AF heritability. On the other hand, two AF loci identified in the Japanese population were both replicated in the Chinese population.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29459676 PMCID: PMC5818533 DOI: 10.1038/s41598-018-21611-7
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Clinical and demographical characteristics of study subjects.
| Characteristics | AF Cases | Controls | |
|---|---|---|---|
| Age (years, mean ± SD) | 61.27 ± 11.33 | 63.8 ± 13.54 | <0.01 |
| Male (%) | 46.37% | 42.18% | 0.03 |
| Coronary artery disease (CAD) (%) | 24.32% | 33.60% | <0.01 |
| Hypertension (HTN) (%) | 44.31% | 48.62% | 0.14 |
| Type 2 diabetes (DM) (%) | 14.86% | 14.26% | 0.31 |
Data are shown as mean +/− standard deviation (SD) for quantitative variables and percentage (%) for qualitative variables.
*The differences between cases and controls for qualitative variables such as gender, hypertension, type 2 diabetes and CAD were analyzed by a Chi-square (χ2) test. The difference for quantitative variables such as means of age was analyzed with a student t test.
AF, atrial fibrillation.
Allelic association analysis between rs4642101, rs13216675, rs6584555 and rs6490029 and AF in the Chinese Han population.
| SNP | Chromosomal Position (hg19) |
| Risk Allele | Risk Allele | Without Adjustment | After Adjustment | Bonferroni correction | ||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
| |||||
| rs4642101 | Chr3: 12842223 | 0.15 | G | 0.29/0.28 | 0.23 | 1.09 | 0.19 | 0.9 (0.79–1.05) | 0.57 |
| rs13216675 | Chr6: 122452329 | 0.03 | T | 0.66/0.61 | 3.9 × 10−3 | 1.2 | 0.01 | 1.19 (1.04–1.35) | 0.04 |
| rs6584555 | Chr10: 105299611 | 0.08 | C | 0.18/0.14 | 5.08 × 10−5 | 1.38 | 9.06 × 10−5 | 1.39 (1.18–1.64) | 3.62 × 10−4 |
| rs6490029 | Chr12: 111698457 | 0.10 | A | 0.74/0.72 | 0.22 | 0.92 | 0.54 | 1.05 (0.90–1.20) | 0.95 |
P, P value for Hardy-Weinberg equilibrium (HWE) tests using PLINK version 1.07 in controls;
P, P value for association before adjusting for covariates by 2 × 2 contingence table χ2 tests using PLINK version 1.07;
P, P value for association after adjusting for covariates of sex, age, HTN, CAD and DM by multiple logistic regression analysis using SPSS v17.0;
OR, odds ratio;
95% CI, 95% confidential interval.
Genotypic association analysis between rs4642101, rs6584555, rs13216675 and rs6490029 and AF under three different genetic models.
| Model* | Genotypes (AA/AB/BB) | Without Adjustment | Adjustment | Bonferroni correction | |||
|---|---|---|---|---|---|---|---|
| Cases | Controls |
|
|
|
|
| |
|
| |||||||
| Additive | 502/392/95 | 620/449/100 | 0.49 | n.a | 0.18 | 0.91 (0.8–1.04) | 0.55 |
| Dominant | 502/487 | 620/549 | 0.29 | 1.10 (0.93–1.30) | 0.26 | 0.9 (0.76–1.1) | 0.70 |
| Recessive | 894/95 | 1069/100 | 0.35 | 1.14 (0.86–1.53) | 0.27 | 0.85 (0.62–1.14) | 0.72 |
|
| |||||||
| Additive | 124/471/460 | 177/476/430 | 6.72 × 10–3 | n.a | 0.01 | 1.19 (1.04–1.35) | 0.04 |
| Dominant | 124/931 | 177/906 | 2.28 × 10−3 | 1.47 (1.15–1.88) | 3.04 × 10−3 | 1.49 (1.14–1.92) | 0.01 |
| Recessive | 595/460 | 653/430 | 0.07 | 1.17 (0.99–1.4) | 0.14 | 0.87 (0.72–1.05) | 0.45 |
|
| |||||||
| Additive | 737/294/50 | 952/290/32 | 4.03 × 10−4 | n.a | 4.85 × 10−5 | 1.41 (1.19–1.67) | 1.94 × 10−4 |
| Dominant | 737/344 | 952/322 | 4.38 × 10−4 | 1.38 (1.15–1.65) | 4.26 × 10−4 | 1.43 (1.16–1.72) | 1.70 × 10−3 |
| Recessive | 1031/50 | 1242/32 | 5.3 × 10−3 | 1.89 (1.2–2.96) | 1.51 × 10−3 | 2.32 (1.37–3.85) | 6.03 × 10−3 |
|
| |||||||
| Additive | 58/412/530 | 97/423/578 | 0.02 | n.a | 0.54 | 0.96 (0.83–1.1) | 0.95 |
| Dominant | 58/942 | 97/1001 | 7.97 × 10−3 | 1.57(1.12–2.2) | 8.28 × 10−3 | 1.61(1.12–2.27) | 0.04 |
| Recessive | 470/530 | 520/578 | 0.87 | 1.01(0.86–1.2) | 0.65 | 1.04 (0.87–1.25) | 0.96 |
*Additive model = AA/AB/BB; dominant model = AA + AB/BB; recessive model = AA/AB + BB;
P, P value for association before adjusting for covariates by 2 × 2 contingence table χ2 test using PLINK version 1.07;
P, P value for association after adjusting for covariates of sex, age, HTN, CAD and DM by multiple logistic regression analysis using SPSS v17.0;
OR, odds ratio;
95% CI, 95% confidential interval.
Estimation of AF heritability explained by SNPs showing significant association in the Chinese Han population.
| Locus | AF heritability explained |
|---|---|
| rs13216675(near the | 1.8% |
| rs6584555( | 3.7% |
| rs6490029( | 2.6% |
| rs2200733 (near | 1.8% |
| rs2106261 ( | 1.7% |
| rs3807989 ( | 2.9% |
|
|
|
Sequences for primers used for HRM genotyping and direct Sanger sequencing analysis.
| SNP | HRM Primers | Sequencing Primers |
|---|---|---|
|
| ||
| Forward primer |
|
|
| Reverse primer |
|
|
|
| ||
| Forward primer |
|
|
| Reverse primer |
|
|
|
| ||
| Forward primer |
|
|
| Reverse primer |
|
|
|
| ||
| Forward primer |
|
|
| Reverse primer |
|
|
HRM, high-resolution melting; SNP, single-nucleotide polymorphism.